And We Have Another Double. Frontier Bio (FBIO) Crosses $4.00.

Roland Rick Perry, Biotech Stock Review, Frontier Bio

Sometimes we Can’t Beleive Our Luck Over the Last Couple Years. But There You Have it, at Least we Know It’s Luck!

While we are not a trading firm, at the same time it’s rare to find us in anything 10 years. But this is our favorite long-term Biotech pick – our Tesla, Netflix, Apple type play. An energizer bunny and incubator that we think can just go and go and go. We’ll be kind of old in ten-years, but you never know.

Unfortunately, Frontier something of the Rodney Dangerfield of Biotechs, so we don’t know what it will take for Wall Street to see what we see (and spurt the price significantly higher) – but it’s nice to be up 100% (two days shy of one year) while we wait!

Woot. Drinks on us tonight. Mask required and hand sanitizer too.

September 4th, 2019: Adding Fortress to Biotech Stock Review Watch List @ $1.73.

February 14th, 2020: Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.


Mustang Bio Announces Orphan Drug Designation for MB-107

Mustang Bio Announces Rare Pediatric Disease Designation for MB-207

Fortress Biotech Announces $60 Million Loan Agreement with Oaktree Capital Management

Fortress Biotech Announces Pricing of Series A Preferred Stock Offering $12 Million